From pattern to patient: microbiome research needs to bridge the gap to the clinic The microbiome has been a trending scientific topic in recent years. Researchers have uncovered correlations between the human microbiome and […] September 7, 2022 · BioVox
VC opportunities for impact in the face of climate disaster Venture capitalists have a vital role to play in guiding our planet’s future. By investing in technological advances that remediate […] September 7, 2022 · V-Bio Ventures
The inspiring potential of gene therapy in neurology Dr. Monica Bennett is Head of Gene Therapy Unit at Novartis, the company behind the world’s only gene therapy approved […] September 7, 2022 · BioVox
V-Bio Ventures portfolio company Biodol Therapeutics nominates its first preclinical candidate as a next-generation therapy for neuropathic pain Ghent, Belgium, 31 August 2022 – V-Bio Ventures portfolio company Biodol Therapeutics, a French biotech company developing next-generation neuropathic pain […] August 31, 2022 · V-Bio Ventures
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform • Closing on € 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs […] August 25, 2022 · V-Bio Ventures
biotope by VIB: helping biotech startups take root in the ecosystem VIB’s new incubator program biotope fosters early biotech startups looking to impact people’s lives through agrifood innovation. Based in the […] August 24, 2022 · BioVox
Augustine Therapeutics: time to reverse nerve damage in patients undergoing chemotherapy or with Charcot-Marie-Tooth disease Augustine Therapeutics is a VIB and KU Leuven spin-off developing innovative therapies for peripheral and central nervous system disorders. The […] August 17, 2022 · V-Bio Ventures
Bacterial biofilms: cooperative bugs cling to food surfaces even after cleaning Current cleaning and disinfection practices in food industries are insufficient to destroy unwanted bacteria lurking on surfaces, according to recent […] August 17, 2022 · SciMingo
Gene therapy pioneer Dr. Katherine High on the past and future of the field Dr. Katherine High is one of gene therapy’s pioneers, who has contributed to a long list of firsts in the […] August 17, 2022 · BioVox
New program fulfills the need for entrepreneurial talent in the life sciences The vibrant Belgian life sciences sector needs a constant influx of young and ambitious entrepreneurs to sustain its growth. The […] June 22, 2022 · Turnstone Communications
Modern alchemy: turning microalgae into ‘green gold’ Much has been said about the huge economic potential of algae, but this ‘green gold’ has yet to meet expectations. […] June 22, 2022 · BioVox
Belgian stakeholders make recommendations for urgently needed data science strategy in healthcare Antwerp, Belgium, 21 June 2022 – Inovigate, a consulting company for the healthcare industry, together with the Belgian Association of […] June 21, 2022 · Turnstone Communications
Belgian stakeholders unite to strive for data science integration in healthcare Data science is booming, including in the healthcare sector. However, in order to extract insights and benefits from our health […] June 15, 2022 · Turnstone Communications
Beethoven and bone conduction: modern hearing solutions based on old tricks The famous composer Ludwig Von Beethoven lost his hearing at a young age. To keep composing, he actively looked for […] June 15, 2022 · SciMingo
Is the dot-com bubble bursting all over again? The stock market value of biotech companies has been crashing lately, bitterly reminiscent of the dot-com bubble burst in the […] June 14, 2022 · V-Bio Ventures